Abstract:Journal of Endovascular Therapy, Ahead of Print. Background:The femoropopliteal arteries are commonly affected by atherosclerotic lesions. The use of atherectomy may increase the benefit of definitive therapy, such as drug-coated balloon (DCB) angioplasty.Purpose:To analyze the 2-year safety and efficacy of atherectomy in general and stratified by directional atherectomy (DA) and front-cutting atherectomy (FA) for the treatment of atherosclerotic lesions of the femoropopliteal arteries.Methods:A retrospective analysis was performed including patients who underwent vessel preparation with atherectomy. The primary endpoint was the 2-year incidence of target lesion revascularization (TLR). Secondary endpoints included primary patency, changes in ankle-brachial index (ABI) and Rutherford-Becker class (RBC), and amputation rate up to 2 years.Results:Nine hundred and fifty-five patients (37.8% female; mean age: 69.7±9.6 years) were included in this analysis. Eight hundred and twenty-one patients (86%) were claudicants, 134 patients (14%) had critical limb-threatening ischemia. Six hundred and forty-four lesions (67.4%) were in a native artery and 145 lesions (15.2%) were in-stent restenoses. In 166 patients (17.4%), atherectomy was performed in native and in-stent segments. Eight hundred and thirty-seven patients were treated with DA and 118 patients with FA. Five-hundred and seventy-four procedures (60.1%) were followed by DCB angioplasty, provisional stent rate was 20% overall. One hundred and fifty-four procedure-related adverse events (16.1%) were documented, four complications (0.4%) required surgical intervention. At 2 years, 279 patients (34.3%) required TLR. After DA, TLR rates were 9%, 19.5%, and 32.2% at 6, 12, and 24 months, respectively, and 14.2%, 29.4%, and 49%, at 6, 12, and 24 months after FA. After DA, primary patency rates were 75.9%, 57.4%, and 40.3% at 6, 12, and 24 months, respectively, and 64.9%, 44.8%, and 26%, at 6, 12, and 24 months, respectively, after FA. Mean ABI and mean RBC improved significantly during follow-up (p<0.001), 17 patients required amputation, 13 minor (1.6%) and four major (0.5%). Regression analysis shows that more calcified lesions are more likely to have a TLR. Compared with a vessel diameter of 4 mm or smaller, larger diameters are associated with fewer TLRs.Conclusion:In this retrospective analysis, atherectomy of femoropopliteal lesions shows satisfactory mid-term results.Clinical Trial Registration:German Clinical Trials Register: DRKS00031245Clinical ImpactThe results of this analysis could influence the daily practice of the interventionalists. A combination of atherectomy as vessel preparation followed by drug coated balloon angioplasty appears to be promising, but would need to be investigated in randomised trials.

Endovascular Treatment of Femoropopliteal Stenoses/occlusions with a SilverHawk Directional Atherectomy Device

Plaque excision with SilverHawk for 42 patients with arteriosclerosis obliterans of lower extremity

Endovascular treatment of femoropopliteal atherosclerotic occlusive disease

Endovascular Nitinol Stenting for Long Occlusive Disease of the Superficial Femoral Artery in Critical Limb Ischemia: A Single-Center, Mid-Term Result

Safety and Efficacy of a Novel Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent for the Treatment of De Novo Coronary Lesions: 12-Month Results from the TARGET II Trial.

The Midterm Outcomes of Endovascular Therapy for Femoropopliteal Lesions via Drug-Coated Balloon, Directional Atherectomy and Bare Metal Stent Angioplasty

Endovascular noninvasive technology for the treatment of atherosclerotic occlusion of infrapopliteal artery

One-Year Clinical Outcome and Risk Factor Analysis of Directional Atherectomy Followed With Drug-Coated Balloon for Femoropopliteal Artery Disease

The clinical efficacy of endovascular intervention for femoropopliteal arteriosclerosis

Endovascular therapy of long occlusive femoral artery

Acute and Mid-Term Results of Atherectomy in Femoropopliteal Lesions

Retrospective observation of directional atherectomy combined with drug-coated balloon angioplasty in treating femoropopliteal arteriosclerosis occlusive disease

Efficacy of intravascular ultrasound guided rotational atherectomy for heavily calcified coronary lesions]

Midterm outcomes of rotational atherectomy-assisted endovascular treatment of severe peripheral arterial disease

Long-term comparison of rotational and directional atherectomy outcomes in patients with femoropopliteal lesions

Short-term Efficacy and Safety of TurboHawk Atherectomy for In-Stent Restenosis in Peripheral Artery Disease: a Single-Centre Experience.

TurboHawk Plaque Excision System in the Treatment of In-Stent Restenosis in Patients with Arteriosclerotic Obliterans: Single Center Experience

Endovascular intervention for infrapopliteal arterial ischemia

Study on mid-term outcomes of atherectomy for patients with femoral popliteal artery lesions with different Global Limb Anatomic Staging System grades

The Efficacy Analysis of Endovascular Intervention Therapy for Transatlantic Inter Society Consensus Type C and Type D Femoropopliteal Arteriosclerosis Lesion

Percutaneous Transluminal Angioplasty and Stent Placement for the Treatment of Long Segmental Atherosclerotic Occlusive Disease of Lower Limb